Dendrimer: A Review
Sheetal B. Gondkar1* Shalaka P. Rasal1, Ravindra B. Saudagar2
1Department of Pharmaceutics, R.G. Sapkal College of Pharmacy Anjaneri, Nashik, Maharashtra, India.
2Department of Pharmaceutical Chemistry, R.G. Sapkal College of Pharmacy Anjaneri, Nashik, Maharashtra, India.
*Corresponding Author E-mail:
ABSTRACT:
Dendrimers are a interesting class of synthetic macromolecules having highly branched, three dimensional, nanoscale architecture with very low polydispersity and high functionality. These features have made their application in nanotechnology, pharmaceutical and medicinal chemistry particularly attractive. This review article is focused on different synthetic strategies used in dendrimer synthesis at commercial and laboratory scale. These synthetic strategies includes their own advantages and disadvantages. This review will cover divergent (from core to surface) and convergent (from surface to core) approaches used in dendrimer synthesis and the problems associated with these synthetic strategies. This article also covers the important applications of dendrimers in the field of pharmaceutical sciences. This data of review is collected from various articles, research papers and patents available on dendrimers.
KEY WORDS:
INTRODUCTION:[1-4]
The term dendrimer is originated from the Greekword ‘Dendron’ which means tree like and ‘meros’ which means parts or unit. Dendrimers are tree like in structure and appearance. It has a three dimensional structural symmetry. A large number of branches during polymer synthesis lead to formation of macromolecule with many end groups. Out of highly branched polymers, dendrimers are perfectly branched uniform structure and hyper branched polymers are randomly branched.
A generally accepted definition of dendrimer is a monodisperse macromolecule with perfectly branched regular structure and having at least one branched junction at each repeat unit. However it is difficult to place, dendritic polymers, especially Dendron’s and dendrimers, definitely in any branch of chemistry. They are sometimes described in terms of supramolecular chemistry or polymer chemistry, although in some cases they are neither supramolecule nor polymer in reality. However they are treated as macromolecules. A structurally perfect dendrimer has monodispersity, defined molecular size, and defined number of end groups. Nano architecture with shell structure, structural precision, hydrophilic or lypophilic balance by design, accessible molecular surface and good flexibility; which offers researchers possibility to work in that particular area. Using distinct properties of the dendrimer in architecture; photo physical, photochemical, electrochemical or catalytic functions at the core of dendrimers have placed active sites for researchers. Present review will have more focus on recent studies and many important applications of dendrimers in various fields of science.
Fig 1: ‘Dendrimer’, ‘Dendron’
PROPERTIES:[5,6]
(1) Dendritic polymers that can be constructed with a well-defined molecular structure, i.e. being mono-disperse, unlike to linear polymers.
(2) Nanoscale sizes that have similar dimensions to important bio-building blocks, e.g., proteins, DNA.
(3) When dendrimer surfaces modified with small functional groups or polyethylene glycol (PEG) show non or low-immunogenicity.
(4) Ability to arrange excretion mode from body, as a function of nanoscale diameter.
(5) An interior void space may be used to encapsulate small molecule drugs, metals, or imaging moieties, reduces the drug toxicity and facilitates controlled release.
(6) Numbers of terminal surface groups suitable for bioconjugation of drugs, signaling groups, targeting moieties or biocompatibility groups.
(7) Surfaces that may be designed with functional groups to resist trans-cellular, epithelial or vascular bio permeability.
(8) Dendrimers are monodisperse macromolecules. Size and molecular mass of dendrimers can be specifically controlled during classical polymerization process.
(9) When the molecular mass of dendrimers increases, their intrinsic viscosity goes through a maximum at the fourth generation and then begins to decline.
(10) The presence of many chain-ends is responsible for high solubility and miscibility and for high reactivity.
(11) Dendrimer solubility is strongly influenced by the nature of surface groups.
(12) The dendrimer should be: nontoxic, on-immunogenic, able to cross bio barriers (biopermeable), able to stay in circulation for the time needed to have a clinical effect and able to target to specific structures.
HISTORY OF DENDRIMER:[7-11]
Dendrimers are an attractive exclusive class of polymers with controlled structure. A dendrimer is both a covalently assemble molecule and also a distinct nanoparticle. The first dendrimers be completed by divergent synthesis advanced by FritzVogtle in 1978, R.G. Denkewalter at Allied Corporation in 1981, Donald Tomalia at DowChemical in 1983 and in 1985, and by George Newkome in 1985. In 1990 a convergent synthetic approach was introduce by Jean Fréchet. A lot of research has already been completed by studying the different properties and application of dendrimers but a lot of researchers still believe it to be in its initial stages.
TYPES OF DENDRIMERS:[12-17]
(1) Radially layered poly (amidoamineorganosilicon) dendrimers (PAMAMOS):
In 1990, Dr. Petar Dvornic and his colleagues at Michigan Molecular Institute discovered this unique first commercial silicon containing dendrimers. Consist of hydrophilic, nucleophilic polyamidoamine (PAMAM) interiors and hydrophobic organosilicon (OS) exteriors. Excellent its networks regularity and ability to complex and encapsulate various guest species offer unprecedented potentials for new applications in nanolithography, lectronics, photonics, chemical catalysis etc. and useful precursors for the preparation of honeycomb like networks with nanoscopicPAMAM and OS domains.
(2) Poly (amidoamine) dendrimers (PAMAM):
Synthesized by the divergent method, starting from initiator core reagents like ammonia or ethylenediamine. When looking at the structure of the high generation in two-dimensions, star like pattern observed. They are commercially available as methanol solutions and ingeneration G 0-10 with 5 different core type and 10 functional surface groups.
(3) Poly (Propylene Imine) dendrimers (PPI):
Poly (Propylene Imine) dendrimers (PPI) generally having poly-alkyl amines as end groups, and numerous tertiary trispropylene amines present in interior portion. It commercially available up to G5, and wide applications in material science as well as in biology.PPI dendrimers are available as Astramol TM.
(4) Chiral dendrimers:
The chirality in these dendrimers is based upon the construction of constitutionally different but chemically similar branches to chiral core. Their potential use as chiral hosts for enantiomeric resolutions and as chiral catalysts for asymmetric synthesis.
(5) Liquid crystalline dendrimers:
A highly-branched oligomer or polymer of dendritic structure containing mesogenic groups that can display mesophase behaviour. They consist of mesogenic (liq. crystalline) monomers e.g. mesogen functionalized carbosilane dendrimers.
(6) Tectodendrimer:
TectoDendrimer are composed of a core dendrimer, perform varied functions ranging from diseased cell recognition, diagnosis of disease state drug delivery, reporting location to reporting outcomes of therapy.
(7) Hybrid dendrimers:
Hybrid dendrimers are hybrids (block or graft polymers) of dendritic and linear polymers. Obtained by complete monofunctionalization of the peripheral amines of a "zero-generation "polyethyleneimine dendrimer, provide structurally diverse lamellar, columnar, and cubic selforganized lattices that are less readily available from other modified dendritic structures.
(8) Multilingual Dendrimers
Multilingual Dendrimers contains multiple copies of a particular functional group on the surface.
(9) Micellar Dendrimers
Micellar dendrimers are unimolecular water soluble hyper branched polyphenylenes micelles.
SYNTHESIS OF DENDRIMER:[18-24]
· Divergent growth method
· Convergent growth method
· Hyper cores and branched monomers growth
· Double exponential growth
First two are the Main two methods for synthesis of dendrimers.
a) Divergent growth method:
This method was introduced by Tomalia. In this method growth of Dendrimers originates from a core site. The core is reacted with two or more moles of reagent containing at least two protecting branching sites, followed by removal of the protecting groups, lead to the first generation dendrimers. This process is repeated until the dendrimer of the described size is obtained. By this approach the first synthesized Dendrimers were polyamidoamines (PAMAM), also known as starbust Dendrimers.
(b) Convergent Dendrimer Growth:
Convergent dendrimer growth begins at what will end up being the surface of the dendrimer, and works inwards by gradually linking surface units together with more. When the growing wedges are large enough, several are attached to a suitable core to give a complete dendrimer. Convergent growth method has An advantage of convergent growth over divergent growth is that purification Is done after each step whereas in divergent method since the reactant and product remains same it is difficult to purify by chromatographic technique. several advantages like relatively easy to purify the desired product, occurrence of defects in the final structure is minimized, does not allow the formation of high generation dendrimer because stearic problems occur in the reactions of the dendrons and the core molecule.
Fig 2: Divergent synthesis of dendrimer
Fig 3: Hypercores’ and ‘Branched Monomers’ growth
Linkage of the oligomeric species in a radial, branch-upon-branch. Core is reacted with two or more moles of reagent containing at least two protecting branching sites, followed by removal of the protecting groups. The subsequent liberated reactive sites lead to the first generation Dendrimers.
Fig 4: ‘Hypercores’ & ‘Branched’ monomer growth
(d) Double Exponential’ or mixed growth
In this approach two products (monomers for both convergent and divergent growth) are reacted together to give an orthogonally protected trimer, which may be used to repeat the growth process again. Strength of double exponential growth is more subtle than the ability to build large dendrimers in relatively few steps.
Fig 5:Double exponential growth
APPLICATION OF DENDRIMERS:[25-32]
Therapeutic Application:
Dendrimer in photodynamic therapy
Dendrimers for Boron Neutron capture therapy
Diagnostic Application:
Dendrimers as MRI contrast agent
Dendrimers as X-Ray contrast
Dendrimer as molecular probe agent
Pharmaceutical Application:
Dendrimers in pulmonary drug delivery
Dendrimers in Transdermal drug delivery
Dendrimers in ocular drug delivery
Dendrimers in oral drug delivery
Dendrimers for controlled release drug delivery
Dendrimers in targeted drug delivery
Dendrimers in gene delivery
Dendrimers as solubility enhancer
Cellular delivery using dendrimers carrier
Dendrimers based product in cosmetics
Dendrimers based commercial products
Dendrimers in Gene Delivery:
Dendrimers can be use as a carrier in gene therapy. Example- PAMAM dendrimers have terminal amino groups which interact with phosphate group of nucleic acid. So PAMAM have been tested as a genetic material vector [15 Super Fect TM is a transfection reagent, it consist of activated dendrimers. Activated dendrimers carry a large amount of genetic material than viruses.
Dendrimers as solubility enhancer:
Dendrimers are unimolecularmicellar in nature because these have both hydrophobic and hydrophilic layer. Hydrophylic layer forms the outer surface. Dendrimers do not have a critical micelle concentration. Due to these properties dendrimers enhance the solubility of poorly soluble drug by forming covalent. Non-covalent complexes with drug molecules and hydrophobes.
Dendrimers as cellular drug delivery carrier:
Pure drug entered into the cell in 3 hours but the dendrimers ibuprofen complexes entered into the cell in 1 hour. So these results show that dendrimers can carry the complex drug efficiently inside the cell.
Dendrimers in targeted and controlled release drug delivery:
The dendrimers facilitate the passive targeting of drug to solid tumours. This is due to their enhanced solubility and plasma circulation time. EPR (Enhanced Permiation and Retention) in tumour tissues leads to reduce cytotoxicity of anticancer drug and increased uptake by cancer cell lines.
Dendrimers in cosmetics:
Dendrimers have a great contribution on cosmetics. Various cosmetic industry used dendrimers in the formulation. L’Oreal has a patent for using dendrimers in the production of cosmetics like mascara or nail polish.
REFERENCES:
1. Tomalia D.A, Baker. H, Dewald J.R, Hall M, Kallos G, Martin S, Roeck J, Ryder J and Smith P., Dendrimers II: Architecture, nanostructure and supramolecular chemistry, Macromolecules, 19: 2466 (1986).
2. Froehling P.E, Dendrimers and dyes – a review, Dyes and pigments, 48:187-195 (2001).
3. Hawker C.J. and Frechet J.M.J, ‘Three- Dimensional Dendritic Macromolecules: Design, Synthesis and Properties’ in new methods of polymer synthesis, edited by J.R. Ebdon and G.C.Eastmond, Chapman and Hall, New York, 290-330 (1995).
4. Karak N, Maiti S, ‘Dendrimers and hyperbranched polymers-synthesis to applications’ MD Publications Pvt Ltd, New Delhi: 1-47 (2008).
5. Sakthivel T, Toth I and Florence AT: Synthesis and physicochemical properties of lipophilic polyamide dendrimers, Pharm. Res., 15, 1998,pp776-782.
6. Peeyushkumar, K.P. Meena, Pramod Kumar, Champalal Choudhary, Devendra Singh Thakur, Pranav Bajpaye; Dendrimer: A Novel Polymer For Drug Delivery; JITPS 2010, Vol.1 (6) pp252-269
7. Gaudana R, Jwala J, Boddu SHS, Mitra AK, Recent perspectives in ocular drug delivery, Pharmaceutical Research, 2009; 26(5): 1197–1216.
8. Ranta VP, Mannermaa E, Lummepuro K, Barrier analysis of periocular drug delivery to the posterior segment. Journal of Controlled Release, 2010; 148(1): 42–48.
9. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P, A New Class of Polymers: Starburst-Dendritic Macromolecules. Polymer Journal, 1985; 17(1): 117-132.
10. Hawker CJ, Fréchet JMJ, Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J. Am. Chem. Soc., 1990; 112(21): 7638-7645.
11. Kolhea P, Misraa E, Kannana RM, Kannanb S, Lieh-Laib M, Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. International Journal of Pharmaceutics, 2003; 259(2003): 143–160.
12. Petar R, Dvornic L, Douglas S, MichaelJ and Owen SP: Radially Layered Co poly(amid amine organ silicon) Dendrimers, United States Patent 1998; 5: 739.
13. Dvornic PR and Owen MJ: Poly (amidamine organ silicon) Dendrimers and Their Derivatives of Higher Degree of Structural Complexity, Synthesis and Properties of Silicones and Silicone-Modified Materials2002: 236-259.
14. Tomalia DA, Dewald JR, Hall MR, Martin SJ and Smith PB: Preprints 1stSPSJ Polymer. Conf. Soc. Polymer. Sci1984; 65.
15. Hawker C and Freshet JJ: J. Chem. Soc.Chem. Commun 1990: 1010
16. Brabander-van den Berg EMM, Meijer EW, Poly (propylene imine) Dendrimers: Large Scale Synthesis by Heterogeneously Catalyzed Hydrogenation. Angew Chem Int Ed Engl; 32: 1308-1311.
17. Sonke S and Tomali A. Dendrimers inbiomedical applications reflections on thefield. Advanced drug delivery Rev 2005;21: 2106-29. .
18. Sonke S and Tomalia DA: Dendrimersin biomedical applications reflections on the Field. Advanced Drug Delivery Reviews 2005; 57: 2106 – 2129.
19. Barbara K and Maria B: Review Dendrimers: properties and applications. ActaBiochimicaPolonica2001; 48: 199- 208.
20. Kandekar UY, Chaudhari PD, Tambe VS, Vichare VS and Dhole SN. Dendrimers: A novel drug nanocarriers. IJPSR. 2011;2(5):1086- 1098.
21. Joaquim MO, Salgadoc AJ, Sousac N, Manoa JA and Reis RL. Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—A review Progress in Polymer Science. 2010;35:1163–1194.
22. Peeyush Kumar et al., “Dendrimer: a novel polymer for drug delivery”, JITPS 2010, 1(6), 252-269.
23. Sonke S, Tomalia DA, “Dendrimers in biomedical applications reflections on the Field”, Advanced Drug Delivery Reviews, 2005, 57,2106 – 2129,.
24. Barbara K and Maria B: Review Dendrimers: properties and applications. ActaBiochimicaPolonica2001; 48: 199-208.Tomalia.
25. Sonke, S. and D.A. Tomalia, 2005. Dendrimers in biomedical application reflection on the field Advanced Drug Delivery Reviews, 57: 2106-2129.
26. Barabara, K. and B. Maria, 2001. Review Dendrimers: properties and applications. Acta Biochimica Polonica, 48: 199-208.
27. Gillies, E.R. and J.M.J. Frechet, 2005. Dendrimers and dendritic polymers in drug delivery. Drug Discovery Today, 10: 35-43.
28. Mohammad, N. and D. Antony, 2006. Crossing cellular barriers using dendrimers nanotechnologies. Current Opinion in Pharmacology, 6: 522-527.
29. Svenson, S. and D.A. Tamalia, 2005. Dendrimers in biomedical application reflection on the field. Adv. Drug Delivery Review, 57: 2106-2129.
30. Use of hyperbranched polymer and dendrimers comparising a particular group as film- forming agent, film forming composition comprisisng same and use particularly in cosmetics and pharmaceutics, L’Oreal, U S Patent 6432423, 2002.
31. Self- tanning cosmetic composition, L’Oreal, U.S Patent 6399048, 2002.
32. Tiwari, D.K., J. Behari and P. Sen, 2008. Application of nanoparticles in waste water treatment. World Applied Science Journal, 3: 417-433.
Received on 24.04.2016 Accepted on 17.05.2016
© Asian Pharma Press All Right Reserved
Asian J. Pharm. Res. 2016; 6(3): 188-192.
DOI: 10.5958/2231-5691.2016.00027.7